MOXIFLOXACIN HYDROC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F1366 to DMS Pharmaceutical Group Inc. for the procurement of Moxifloxacin Hydrocloride, identified by NSN 6505015090677. This award was issued as a delivery order under the broader commercial items contract SPE2DX15D9383, managed by the DLA Troop Support Medical Supply Chain FSB. Subsequent to the award, modification P00001 was executed to cancel CLIN 0001 at no cost to either party, citing a termination for the Government's convenience under FAR 52.212-4(i). This action was taken to address aged delivery orders associated with the vendor, resulting in a contract amount decrease of 112.66 dollars, bringing the total value of the order to zero dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
